FIELD: chemistry; biochemistry.
SUBSTANCE: invention pertains to bioengineering. A modified peptide is obtained via a recombinant method. The obtained peptide is effective in treating and preventing metabolic disorders such as obesity, diabetes and increased risk of cardiovascular diseases.
EFFECT: obtaining a peptide with amylin properties, which can be used in medicine.
16 cl, 16 dwg, 10 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATING DIABETES AND METABOLIC SYNDROME | 2010 |
|
RU2537181C2 |
| PEPTIDE ANTAGONISTS OF CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE | 2017 |
|
RU2742826C2 |
| PEPTIDE ANTAGONISTS OF PEPTIDE HORMONES FROM THE CALCITONIN GROUP (CALCITONIN GENE-RELATED PEPTIDES (CGRP)) AND THEIR APPLICATION | 2013 |
|
RU2624016C2 |
| METHOD FOR INHIBITING GLUCAGON | 2000 |
|
RU2247575C9 |
| INSULIN ANALOGUES WITH REDUCED AFFINITY TO INSULIN RECEPTOR AND THEIR USE | 2017 |
|
RU2764197C1 |
| INSULIN ANALOGUE COMPLEX WITH REDUCED AFFINITY TO INSULIN RECEPTOR AND ITS USE | 2018 |
|
RU2779462C2 |
| CONJUGATE OF LONG-ACTING PHYSIOLOGICALLY ACTIVE SUBSTANCE AND ITS USE | 2018 |
|
RU2773823C2 |
| POLYPEPTIDES | 2012 |
|
RU2669999C2 |
| COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | 2014 |
|
RU2771808C2 |
| PEPTIDE ANALOGS FOR TREATMENT OF DISEASES AND DISORDERS | 2012 |
|
RU2616511C2 |
